title: Should patients with cirrhosis and variceal hemorrhage receive glucocorticoid therapy?
authors.affiliation: Inserm, U1149, Centre de Recherche sur l'Inflammation, Paris, France; UMR S 1149, Université Paris Diderot-Paris 7, Faculté de Médecine Bichat, Paris, France; Département Hospitalo-Universitaire UNITY, Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France; Laboratoire d'Excellence (Labex) INFLAMEX, PRES Sorbonne Paris Cité, Paris, France.
authors.forename: Richard
authors.initials: R
authors.lastname: Moreau
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Weiss
mesh_terms: D000302:Adrenal Cortex / Q000378:metabolism*; D016638:Critical Illness / Q000401:mortality*; D004932:Esophageal and Gastric Varices / Q000401:mortality*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000401:mortality*; D006801:Humans; D008103:Liver Cirrhosis / Q000401:mortality*; D008297:Male